←Back to Expert Scholars
Translational Medicine / 转化医学HER2 NSCLC, Thoracic Oncology
Misako Nagasaka
MD, PhD
🏢University of California Irvine🌐USA
Associate Professor of Medicine
40
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Misako Nagasaka is a thoracic oncologist with deep expertise in HER2 mutant NSCLC and early phase trials. She has published extensively on HER2 targeted therapies and novel ADCs in lung cancer. Her international collaborations support drug development across North America and Asia.
Share:
🧪Research Fields 研究领域
HER2 NSCLC
thoracic oncology
drug development
ADC
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Misako Nagasaka 的研究动态
Follow Misako Nagasaka's research updates
留下邮箱，当我们发布与 Misako Nagasaka（University of California Irvine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment